Cargando…

Immune Checkpoint Inhibitors in the Treatment of HCC

Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often prospers where a chronic liver disease persists, thus leading a strong rationale for immune therapy. Several immune-based treatments, including immune checkpoint inhibitors (ICI), cytokines, adoptive cell transfer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donisi, Clelia, Puzzoni, Marco, Ziranu, Pina, Lai, Eleonora, Mariani, Stefano, Saba, Giorgio, Impera, Valentino, Dubois, Marco, Persano, Mara, Migliari, Marco, Pretta, Andrea, Liscia, Nicole, Astara, Giorgio, Scartozzi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874239/ https://www.ncbi.nlm.nih.gov/pubmed/33585218 http://dx.doi.org/10.3389/fonc.2020.601240

Ejemplares similares

Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
por: Spanu, Dario, et al.
Publicado: (2022)

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
por: Lai, Eleonora, et al.
Publicado: (2020)

Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?
por: Pretta, Andrea, et al.
Publicado: (2022)

CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
por: Ziranu, Pina, et al.
Publicado: (2023)

New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
por: Ziranu, Pina, et al.
Publicado: (2023)

How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world
por: Pretta, Andrea, et al.
Publicado: (2022)

The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review
por: Massa, Elena, et al.
Publicado: (2021)

Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers
por: Zhang, Ruyi, et al.
Publicado: (2021)

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
por: Mariani, Stefano, et al.
Publicado: (2022)

The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
por: Ziranu, Pina, et al.
Publicado: (2021)

EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
por: Madeddu, Clelia, et al.
Publicado: (2022)

Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2020)

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023)

Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab
por: Giampieri, Riccardo, et al.
Publicado: (2021)

Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2021)

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
por: Demurtas, Laura, et al.
Publicado: (2017)

From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
por: Giampieri, Riccardo, et al.
Publicado: (2020)

HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
por: Loi, Eleonora, et al.
Publicado: (2022)

Cancer cachexia and chronic inflammation: an unbreakable bond
por: Macciò, Antonio, et al.
Publicado: (2023)

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials
por: Casadei Gardini, Andrea, et al.
Publicado: (2019)

Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
por: Madeddu, Clelia, et al.
Publicado: (2018)

Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
por: Macciò, Antonio, et al.
Publicado: (2009)

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023)

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
por: Faloppi, Luca, et al.
Publicado: (2014)

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review
por: Gardini, Andrea Casadei, et al.
Publicado: (2017)

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
por: Sharma, Rohini, et al.
Publicado: (2022)

Clustered protocadherins methylation alterations in cancer
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2019)

Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report
por: Madeddu, Clelia, et al.
Publicado: (2022)

Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature
por: Zardi, Enrico M, et al.
Publicado: (2008)

The Predictive Factors of New Technology Adoption, Workers’ Well-Being and Absenteeism: The Case of a Public Maritime Company in Venice
por: Panari, Chiara, et al.
Publicado: (2021)

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant
por: Anugwom, Chimaobi M., et al.
Publicado: (2022)

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)

Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC
por: Marzi, Luca, et al.
Publicado: (2022)

Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE
por: Fronda, Marco, et al.
Publicado: (2021)

A Liver Index and its Relationship to Indices of HCC Aggressiveness
por: Carr, Brian I, et al.
Publicado: (2016)

Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
por: Dell’Aquila, Emanuela, et al.
Publicado: (2020)

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
por: Migliari, Silvia, et al.
Publicado: (2023)

Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
por: Dong, Yawen, et al.
Publicado: (2021)

Measuring HCC Tumor Size in MRI—The Sequence Matters!
por: Armbruster, Marco, et al.
Publicado: (2021)

Uterine leiomyoma in pediatric population: A case report and review of the literature
por: Martucci, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rr4i7n75lucc91slfli0qk8009